Cargando…

R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation

This study aimed to characterize the protective effects of R. verniciflua extract (ILF-R) and E. ulmoides extract (ILF-E), the combination called ILF-RE, against chronic CCl(4)-induced liver oxidative injury in rats, as well as to investigate the mechanism underlying hepatoprotection by ILF-RE again...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hwa-Young, Lee, Geum-Hwa, Yoon, Young, Chae, Han-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412399/
https://www.ncbi.nlm.nih.gov/pubmed/30759889
http://dx.doi.org/10.3390/nu11020382
_version_ 1783402596425269248
author Lee, Hwa-Young
Lee, Geum-Hwa
Yoon, Young
Chae, Han-Jung
author_facet Lee, Hwa-Young
Lee, Geum-Hwa
Yoon, Young
Chae, Han-Jung
author_sort Lee, Hwa-Young
collection PubMed
description This study aimed to characterize the protective effects of R. verniciflua extract (ILF-R) and E. ulmoides extract (ILF-E), the combination called ILF-RE, against chronic CCl(4)-induced liver oxidative injury in rats, as well as to investigate the mechanism underlying hepatoprotection by ILF-RE against CCl(4)-induced hepatic dysfunction. Chronic hepatic stress was induced via intraperitoneal (IP) administration of a mixture of CCl(4) (0.2 mL/100 g body weight) and olive oil [1:1(v/v)] twice a week for 4 weeks to rats. ILF-RE was administered orally at 40, 80, and 120 mg/kg to rats for 4 weeks. Alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transpeptidase (GGT), and lipid peroxidation assays were performed, and total triglyceride, cholesterol, and LDL-cholesterol levels were quantified. Furthermore, ER stress and lipogenesis-related gene expression including sterol regulatory element-binding transcription factor 1 (SREBP-1), fatty acid synthase (FAS), and P-AMPK were assessed. ILF-RE markedly protected against liver damage by inhibiting oxidative stress and increasing antioxidant enzyme activity including glutathione (GSH), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase. Furthermore, hepatic dyslipidemia was regulated after ILF-RE administration. Moreover, hepatic lipid accumulation and its associated lipogenic genes, including those encoding SREBP-1 and FAS, were regulated after ILF-RE administration. This was accompanied by regulation of ER stress response signaling, suggesting a mechanism underlying ILF-RE-mediated hepatoprotection against lipid accumulation. The present results indicate that ILF-RE exerts hepatoprotective effects against chronic CCl(4)-induced dysfunction by suppressing hepatic oxidative stress and lipogenesis, suggesting that ILF-RE is a potential preventive/therapeutic natural product in treating hepatoxicity and associated dysfunction.
format Online
Article
Text
id pubmed-6412399
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64123992019-03-29 R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation Lee, Hwa-Young Lee, Geum-Hwa Yoon, Young Chae, Han-Jung Nutrients Article This study aimed to characterize the protective effects of R. verniciflua extract (ILF-R) and E. ulmoides extract (ILF-E), the combination called ILF-RE, against chronic CCl(4)-induced liver oxidative injury in rats, as well as to investigate the mechanism underlying hepatoprotection by ILF-RE against CCl(4)-induced hepatic dysfunction. Chronic hepatic stress was induced via intraperitoneal (IP) administration of a mixture of CCl(4) (0.2 mL/100 g body weight) and olive oil [1:1(v/v)] twice a week for 4 weeks to rats. ILF-RE was administered orally at 40, 80, and 120 mg/kg to rats for 4 weeks. Alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamyl transpeptidase (GGT), and lipid peroxidation assays were performed, and total triglyceride, cholesterol, and LDL-cholesterol levels were quantified. Furthermore, ER stress and lipogenesis-related gene expression including sterol regulatory element-binding transcription factor 1 (SREBP-1), fatty acid synthase (FAS), and P-AMPK were assessed. ILF-RE markedly protected against liver damage by inhibiting oxidative stress and increasing antioxidant enzyme activity including glutathione (GSH), glutathione peroxidase (GPx), superoxide dismutase (SOD), and catalase. Furthermore, hepatic dyslipidemia was regulated after ILF-RE administration. Moreover, hepatic lipid accumulation and its associated lipogenic genes, including those encoding SREBP-1 and FAS, were regulated after ILF-RE administration. This was accompanied by regulation of ER stress response signaling, suggesting a mechanism underlying ILF-RE-mediated hepatoprotection against lipid accumulation. The present results indicate that ILF-RE exerts hepatoprotective effects against chronic CCl(4)-induced dysfunction by suppressing hepatic oxidative stress and lipogenesis, suggesting that ILF-RE is a potential preventive/therapeutic natural product in treating hepatoxicity and associated dysfunction. MDPI 2019-02-12 /pmc/articles/PMC6412399/ /pubmed/30759889 http://dx.doi.org/10.3390/nu11020382 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Hwa-Young
Lee, Geum-Hwa
Yoon, Young
Chae, Han-Jung
R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation
title R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation
title_full R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation
title_fullStr R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation
title_full_unstemmed R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation
title_short R. verniciflua and E. ulmoides Extract (ILF-RE) Protects against Chronic CCl(4)-Induced Liver Damage by Enhancing Antioxidation
title_sort r. verniciflua and e. ulmoides extract (ilf-re) protects against chronic ccl(4)-induced liver damage by enhancing antioxidation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412399/
https://www.ncbi.nlm.nih.gov/pubmed/30759889
http://dx.doi.org/10.3390/nu11020382
work_keys_str_mv AT leehwayoung rvernicifluaandeulmoidesextractilfreprotectsagainstchronicccl4inducedliverdamagebyenhancingantioxidation
AT leegeumhwa rvernicifluaandeulmoidesextractilfreprotectsagainstchronicccl4inducedliverdamagebyenhancingantioxidation
AT yoonyoung rvernicifluaandeulmoidesextractilfreprotectsagainstchronicccl4inducedliverdamagebyenhancingantioxidation
AT chaehanjung rvernicifluaandeulmoidesextractilfreprotectsagainstchronicccl4inducedliverdamagebyenhancingantioxidation